PDC*line cells were loaded with the peptides inducing the best T-cell responses (NY-ESO-1, CAMEL, MAGE-A2, MAGE-A3, and MAGE-A9) and used to stimulate PBMCs from eight new NSCLC patients. Here, CTAG2 is linked to non-small cell lung carcinoma.